Bcworldpharm
비씨월드제약 · 200780
Health Care Pharmaceuticals · KOSDAQ
Market cap US$29M (₩40B)
Overview
Bcworldpharm makes prescription medicines, drugs used to treat, prevent, and manage a range of diseases, and supplies them to domestic pharmaceutical companies as well as exporting to markets across Europe, Latin America, the Middle East, CIS countries, and Asia.
Listed on KOSDAQ, Korea's small-cap and technology board, it serves both end-market customers and other drug makers that outsource manufacturing. Beyond its own branded products, the company operates contract manufacturing (CMO) and contract development-and-manufacturing (CDMO) businesses, and is also pursuing overseas licensing of its in-house research and development technology.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$54.4M
- FY2024US$54.2M
- FY2025US$54.9M
Operating profit
- FY2023US$4.6M
- FY2024US$1.1M
- FY2025US$1.4M
Net income
- FY2023US$2.1M
- FY2024−US$2.4M
- FY2025−US$2.3M
Key ratios (FY2025)
Why it matters
Bcworldpharm consolidates two subsidiaries, 비씨월드헬스케어, a prescription-drug maker, and 하트애드, an advertising agency, into its group financial statements.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?